摘要
目的探讨发生肝转移的乳腺癌患者采用全身化疗联合经肝动脉化疗栓塞术(TACE)治疗的效果。方法选取2012年12月-2014年12月于山东省医学科学院附属医院接受治疗的乳腺癌并发肝转移女性患者86例,将其平均分为试验组和对照组。对照组采用全身化疗,试验组给予全身化疗基础上联合TACE治疗,比较2组临床疗效、病灶变化情况以及治疗后患者生活质量评分情况。计量资料组间比较采用t检验,计数资料组间比较采用χ2检验。结果试验组患者治疗的总有效率高于对照组,差异有统计学意义(90.70%vs 58.14%,χ2=13.07,P=0.001);与对照组相比,试验组患者治疗后肿瘤直径、淋巴结直径较小,差异均有统计学意义(t值分别为4.26、4.63,P值均<0.001);试验组患者治疗后3、6个月生活质量评分均高于对照组,差异均有统计学意义(t值分别为6.30、3.89,P值均<0.001)。结论对乳腺癌肝转移患者采用全身化疗联合TACE治疗的效果显著,能够改善患者症状,减少药物不良反应,提高生活质量,且安全可靠,值得推广应用。
Objective To investigate the clinical effect of systemic chemotherapy combined with transcatheter arterial chemoembolization （TACE） in the treatment of breast cancer with liver metastases. Methods A total of 86 female breast cancer patients with liver metastases who were treated in the Affiliated Hospital of Shandong Academy of Medical Sciences from December 2012 to December 2014 were selected and equally divided into experimental group and control group. The patients in the control group received systemic chemotherapy, and those in the experimental group received systemic chemotherapy combined with TACE. The clinical effect, changes in lesions, and patients＇ quali- ty of life （QOL） scores after treatment were compared between two groups. The t - test was applied for comparison of continuous data be- tween the two groups, and the chi - square test was applied for comparison of categorical data between the two groups. Results The experi- mental group had a significantly higher overall response rate than the control group （90.70% vs 58.14%, χ2 = 13.07, P =0.001 ）. Compared with the control group, the experimental group had significantly smaller diameters of tumors and lymph nodes after treatment （ t = 4. 26 and 4.63, both P 〈 0. 001 ）, as well as significantly higher QOL scores at 3 and 6 months after treatment （ t = 6.30 and 3.89, both P 〈 0. 001 ）. Conclusion Systemic chemotherapy combined with TACE has a significant therapeutic effect in breast cancer patients with liver metastases, and can improve patients＇ symptoms, reduce adverse drug reactions, and improve QOL. As a safe and reliable therapeutic meth- od, it is worthy of clinical application.
出处
《临床肝胆病杂志》
CAS
2016年第1期97-100,共4页
Journal of Clinical Hepatology
关键词
乳腺肿瘤
肿瘤转移
药物疗法
化学栓塞
治疗性
breast neoplasms
neoplasm metastasis
drug therapy
chemoembolization, therapeutic
